Drug Shortage Report for OMNIPAQUE 300

Last updated on 2022-05-13 History
Report ID 160389
Drug Identification Number 02172747
Brand name OMNIPAQUE 300
Common or Proper name iohexol injection USP
Company Name GE HEALTHCARE CANADA INC
Market Status MARKETED
Active Ingredient(s) IOHEXOL
Strength(s) 647MG
Dosage form(s) SOLUTION
Route of administration INTRAVASCULAR SUBARACHNOIDAL
Packaging size 200 mL
ATC code V08AB
ATC description X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-05-12
Estimated end date 2022-06-15
Actual end date
Shortage status Actual shortage
Updated date 2022-05-13
Company comments Covid related shutdown in China
Health Canada comments
Tier 3 Status No
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@ge.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-05-13 English Compare
v2 2022-05-12 French Compare
v1 2022-05-12 English Compare

Showing 1 to 3 of 3